Cleveland Clinic Cancer Center highlights top 10 abstracts to watch for at ASTRO 2023.
Read MorePatient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis
Cleveland Clinic physician shares case of a patient with advanced triple-negative breast cancer achieving a durable response to 4th line therapy.
Honoring Values for Patients With Serious Illness
Palliative medicine specialist Laura Shoemaker, DO, believes that it’s key for physicians to begin a difficult conversation by finding out what the patient knows about their condition. “Ask what they’ve been told and what their understanding of that is. Find out what’s most important to them.”
Pirtobrutinib Shows Promise for Older, Heavily Pretreated Patients with CLL
Non-covalent BTK inhibitor found effective in some heavily pretreated patients with CLL.
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood
Numerous cancer treatments have been shown to have side effects such as ocular toxicities.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Difficult Disclosures in Pediatric Oncology
Pediatric oncologist Seth Rotz, MD, says that when he has difficult news to share with a patient and their family, “I feel obliged to tell them as soon as it’s safe to tell them.”
Blurry Vision, Ocular Motility Issues: Cancer Metastasis to the Eye Takes Many Forms
Cancer metastasis to the eye can manifest as ocular motility issues, blurry vision, and sunken or bulging eyes. Ophthalmologists can contribute to prompt diagnosis and treatment to improve a patient’s quality of life.
CME Program Takes Multidisciplinary Approach to Colorectal Cancer
Two-day CME program highlights the latest diagnostic and treatment options for colorectal cancer.
Study Explores VTE Risk Among Patients with Multiple Myeloma During the Peri-Transplant Period
A recent study uncovered risk factors for venous thromboembolism among patients with multiple myeloma post autologous hematopoietic cell transplant.
Intracoronary Brachytherapy Shown to Be Viable Option for DES In-Stent Restenosis
Intracoronary brachytherapy is a safe and feasible, albeit imperfect, option for treating recurrent drug-eluting stent in-stent restenosis, a new Cleveland Clinic retrospective analysis finds.
Measuring Residual Disease in Leukemias: Improving on Current Assays is a Focus
Next-generation sequencing may improve upon existing methods for measuring minimal residual disease in patients with AML or myelodysplastic syndrome who have received a allogeneic hematopoietic stem cell transplant.